Real-world data supports Opdivo plus Yervoy efficacy for advanced renal cell carcinoma, mirroring clinical trial results.

The company has roaming agreements with 400+ cellular carriers worldwide, which are accessible from over 200 cruise ships. In those cases, travelers’ devices will automatically connect to the network ...

Joe DePinto, MBA, discussed the findings of the McKesson 2024 Cell and Gene Therapy Report, providing insight into the ...

A new Opinium survey of 2,000 UK adults, which was commissioned by Uswitch.com and conducted on 7th Jan 2025, has claimed ...

Imugene has dosed the first Australian subject in a Phase Ib trial of its allogeneic CAR T-cell therapy, azer-cel (azercabtagene zapreleucel).

VMT-a-NET is under clinical development by Perspective Therapeutics and currently in Phase II for Small-Cell Lung Cancer.

A planning commission in a Virginia county has voted unanimously to recommend denial of a rezoning application from Balico ...

This is a useful study that adds new data to how different DAG pools influence cellular signaling, and dissects how the enzyme Dip2 modulates the minor lipid signaling DAG pool, which is distinct from ...

A MAJOR mobile firm is hiking bills for up to one million customers within weeks. Sky Mobile is increasing both pay monthly ...

At the heart of Industry 4.0’s digital revolution lies the transformation of RAN. By moving from static, centralized systems ...

Tamil Nadu Turtle Guardians app tracks sea turtle nesting data, hatchling releases, and aims to enhance conservation efforts.